bioAffinity Technologies, Inc.
BIAF
$0.3535
-$0.0115-3.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.33% | -48.29% | 5.19% | -7.57% | 17.34% |
| Total Depreciation and Amortization | 0.65% | 1.52% | 0.13% | 1.00% | 0.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.51% | 26.06% | -35.12% | 0.88% | 20.98% |
| Change in Net Operating Assets | -40.42% | 2,086.78% | -132.29% | 117.20% | -318.82% |
| Cash from Operations | 2.11% | 1.87% | -11.54% | 34.68% | -45.15% |
| Capital Expenditure | -- | 100.00% | 66.78% | 31.64% | -408.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 66.78% | 31.64% | -408.96% |
| Total Debt Issued | -- | -137.00% | 29,200.00% | -103.25% | -- |
| Total Debt Repaid | -52.97% | 0.00% | -0.66% | -1.92% | -4.60% |
| Issuance of Common Stock | -47.10% | 47.28% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 200.00% | -- |
| Cash from Financing | -49.06% | 21.03% | 1,937.43% | -104.51% | 2,480.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -289.45% | 880.09% | 97.29% | -348.40% | 78.17% |